Literature DB >> 6886827

Plasma amino acid concentrations in normal adults fed meals with added monosodium L-glutamate and aspartame.

L D Stegink, L J Filer, G L Baker.   

Abstract

Aspartame is a dipeptide sweetener containing aspartate. It has been suggested that aspartame addition to meals containing large amounts of monosodium L-glutamate (MSG) would result in a rapid rise in plasma glutamate and/or aspartate concentrations and increase the potential for dicarboxylic amino acid--induced toxicity. Sic normal adult subjects were fed three hamburger and milk shake meals providing protein at 1 g/kg body weight in a Latin square design. One meal had no additions, the second provided MSG at 150 mg/kg body weight, and the third provided MSG at 150 mg/kg body weight and aspartame at 23 mg/kg body weight. The addition of MSG alone significantly increased plasma glutamate + aspartate concentration above values noted after ingestion of the meal alone. Aspartame addition to meals already containing MSG did not further significantly increase plasma glutamate + aspartate concentration above values noted when only MSG was added. However, aspartame addition did significantly increase the mean plasma phenylalanine concentration above values noted after ingestion of the meal alone or the meal with added MSG, reflecting aspartame's phenylalanine content. The data do not support the suggestion that aspartame addition to high protein meals already containing large amounts of MSG, will promote a rapid and dangerous rise in plasma glutamate and aspartate concentrations.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6886827     DOI: 10.1093/jn/113.9.1851

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  12 in total

Review 1.  Risk Assessment Paradigm for Glutamate.

Authors:  Ashley Roberts; Barry Lynch; Ivonne M C M Rietjens
Journal:  Ann Nutr Metab       Date:  2018-12-03       Impact factor: 3.374

2.  Glutamate, a metabolic biomarker of aggressiveness and a potential therapeutic target for prostate cancer.

Authors:  Shahriar Koochekpour
Journal:  Asian J Androl       Date:  2013-01-14       Impact factor: 3.285

Review 3.  Could Dietary Glutamate Play a Role in Psychiatric Distress?

Authors:  A Zarina Kraal; Nicole R Arvanitis; Andrew P Jaeger; Vicki L Ellingrod
Journal:  Neuropsychobiology       Date:  2019-01-30       Impact factor: 2.328

4.  Molecular biology of the blood-brain and the blood-cerebrospinal fluid barriers: similarities and differences.

Authors:  Zoran Redzic
Journal:  Fluids Barriers CNS       Date:  2011-01-18

Review 5.  Glutamate: A Safe Nutrient, Not Just a Simple Additive.

Authors:  Cécile Loï; Luc Cynober
Journal:  Ann Nutr Metab       Date:  2022-02-16       Impact factor: 5.923

6.  The blood-brain barrier and glutamate.

Authors:  Richard A Hawkins
Journal:  Am J Clin Nutr       Date:  2009-07-01       Impact factor: 7.045

Review 7.  Brain to blood glutamate scavenging as a novel therapeutic modality: a review.

Authors:  Matthew Boyko; Shaun E Gruenbaum; Benjamin F Gruenbaum; Yoram Shapira; Alexander Zlotnik
Journal:  J Neural Transm (Vienna)       Date:  2014-03-13       Impact factor: 3.575

8.  Measurement in saliva from neurotypical adults of biomarkers pertinent to autism spectrum disorders.

Authors:  Helen V Ratajczak; Robert B Sothern
Journal:  Future Sci OA       Date:  2015-11-01

Review 9.  Pancreatic β-Cell Electrical Activity and Insulin Secretion: Of Mice and Men.

Authors:  Patrik Rorsman; Frances M Ashcroft
Journal:  Physiol Rev       Date:  2018-01-01       Impact factor: 37.312

10.  Further studies are necessary in order to conclude a causal association between the consumption of monosodium L-glutamate (MSG) and the prevalence of metabolic syndrome in the rural Thai population.

Authors:  Michael D Rogers
Journal:  Nutr Metab (Lond)       Date:  2013-01-24       Impact factor: 4.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.